Breaking News Instant updates and real-time market news.

IBB

iShares Nasdaq Biotechnology Index

$105.33

-0.37 (-0.35%)

06:42
04/12/18
04/12
06:42
04/12/18
06:42

iShares Nasdaq Biotechnology Index: Pivot points

The following are the pivot points for the iShares Nasdaq Biotechnology Index (IBB). Pivot High: $107.16, Pivot Low: $104.99. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

IBB iShares Nasdaq Biotechnology Index
$105.33

-0.37 (-0.35%)

11/14/17
CANT
11/14/17
NO CHANGE
Target $31
CANT
Overweight
Cantor sees TherapeuticsMD being added to Biotechnology Index on Dec. 15
Cantor Fitzgerald's Tracker Quants team predicts TherapeuticsMD (TXMD) will be added to the Nasdaq Biotechnology Index (IBB) on December 15 and that passive trackers will need to buy 34.5M shares of the company. This may provide additional share upside in the short term, Cantor analyst William Tanner tells investors in a research note. He reiterates an Overweight rating on TherapeuticsMD while trimming his price target for the shares to $31 from $32. The women's healthcare company closed yesterday up 23c to $5.90. Tanner continues to believe TherapeuticsMD's TX-004 will be an important new therapy for vulvar vaginal atrophy.
04/02/18
JEFF
04/02/18
NO CHANGE
JEFF
Buy
Alnylam weakness on Pfizer data a buying opportunity, says Jefferies
Jefferies analyst Maury Raycroft noted that Alnylam (ALNY) fell by over 8% on Thursday after Pfizer (PFE) announced that the phase 3 ATTR-ACT trial assessing tafamidis in TTR-CM met its primary endpoint and that Alnylam shares are trailing the iShares Nasdaq Biotechnology Index (IBB) again today. While he thinks the tafamidis data provide important clinical outcome results that support the need for treatment and benefit in TTR-CM, he also continues to believe the benefits of knocking down/depleting TTR in earlier-stage patients, as Alnylam's patisiran is meant to do, will lead to better objective improvements, Raycroft tells investors. The analyst, who recommends investors buy Alnylam amid the weakness, keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

MSGN

MSG Networks

$25.48

-0.53 (-2.04%)

13:20
11/15/18
11/15
13:20
11/15/18
13:20
Hot Stocks
MSG Networks announces sponsorship deal for Devils broadcasts with William Hill »

MSG Networks and William…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
11/15/18
11/15
13:20
11/15/18
13:20
General news
Atlanta Fed's Q4 GDPNow estimate was trimmed to 2.8% »

Atlanta Fed's Q4…

CVS

CVS Health

$79.23

-0.69 (-0.86%)

, AET

Aetna

$207.58

-0.58 (-0.28%)

13:17
11/15/18
11/15
13:17
11/15/18
13:17
Hot Stocks
California regulator approves CVS's acquisition of Aetna »

The California Department…

CVS

CVS Health

$79.23

-0.69 (-0.86%)

AET

Aetna

$207.58

-0.58 (-0.28%)

WCG

WellCare

$246.88

-4.14 (-1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/15/18
11/15
13:17
11/15/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCO

Clear Channel Outdoor

$5.51

0.19 (3.57%)

, OUT

Outfront Media

$21.01

0.32 (1.55%)

13:16
11/15/18
11/15
13:16
11/15/18
13:16
Periodicals
Clear Channel Outdoor rises after JCDecaux CEO expresses takeover interest »

JCDecaux (JCDXF) CEO…

CCO

Clear Channel Outdoor

$5.51

0.19 (3.57%)

OUT

Outfront Media

$21.01

0.32 (1.55%)

JCDXF

JCDecaux

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/15/18
11/15
13:16
11/15/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
11/15/18
11/15
13:15
11/15/18
13:15
General news
Atlanta Fed dove Bostic wants to "proceed cautiously" »

Atlanta Fed dove Bostic…

FB

Facebook

$142.11

-2.14 (-1.48%)

13:12
11/15/18
11/15
13:12
11/15/18
13:12
Hot Stocks
Facebook comments on progress enforcing community standards »

Facebook comments on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

CCO

Clear Channel Outdoor

$5.21

-0.11 (-2.07%)

, OUT

Outfront Media

$20.64

-0.05 (-0.24%)

13:11
11/15/18
11/15
13:11
11/15/18
13:11
Periodicals
Breaking Periodicals news story on Clear Channel Outdoor, Outfront Media »

JCDecaux has expressed…

CCO

Clear Channel Outdoor

$5.21

-0.11 (-2.07%)

OUT

Outfront Media

$20.64

-0.05 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

NICE

Nice Systems

$110.77

0.48 (0.44%)

13:11
11/15/18
11/15
13:11
11/15/18
13:11
Conference/Events
Nice Systems management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

UNIT

Uniti Group

$18.54

-0.68 (-3.54%)

13:10
11/15/18
11/15
13:10
11/15/18
13:10
Options
Second day of put buying in Uniti Group as shares display relative weakness »

Second day of put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$18.11

2 (12.41%)

13:05
11/15/18
11/15
13:05
11/15/18
13:05
Options
Amarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYB

RYB Education

$7.51

-9.3 (-55.32%)

, BEDU

Bright Scholar

$10.34

-2.435 (-19.07%)

13:02
11/15/18
11/15
13:02
11/15/18
13:02
Hot Stocks
RYB, Bright Scholar slide on new Chinese stock policy for private kindergartens »

Shares of RYB Education…

RYB

RYB Education

$7.51

-9.3 (-55.32%)

BEDU

Bright Scholar

$10.34

-2.435 (-19.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

AVEO

Aveo Pharmaceuticals

$1.86

-0.04 (-2.11%)

13:01
11/15/18
11/15
13:01
11/15/18
13:01
Recommendations
Aveo Pharmaceuticals analyst commentary  »

Piper Jaffray sees FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

SPI

SPI Energy

$0.26

-0.001 (-0.38%)

13:01
11/15/18
11/15
13:01
11/15/18
13:01
Hot Stocks
SPI Energy announces 10-for-1 share consolidation »

SPI Energy announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMYT

MakeMyTrip

$23.74

-0.15 (-0.63%)

13:01
11/15/18
11/15
13:01
11/15/18
13:01
Conference/Events
MakeMyTrip management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

TSLA

Tesla

$344.69

0.62 (0.18%)

12:57
11/15/18
11/15
12:57
11/15/18
12:57
Hot Stocks
Musk says Tesla acquired trucking capacity to ensure Model 3 delivery by Dec 31 »

Tesla CEO Elon Musk said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 13

    Dec

NURO

NeuroMetrix

$1.02

0.01 (0.99%)

12:55
11/15/18
11/15
12:55
11/15/18
12:55
Hot Stocks
NeuroMetrix executes distribution agreement with Fukuda Denshi »

NeuroMetrix announced …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

COST

Costco

$229.02

-4.24 (-1.82%)

12:55
11/15/18
11/15
12:55
11/15/18
12:55
Options
Costco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$189.70

2.89 (1.55%)

12:46
11/15/18
11/15
12:46
11/15/18
12:46
Periodicals
Tepper's Appaloosa sold position in Apple, CNBC reports »

David Tepper's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSC

WillScot

$15.38

-0.35 (-2.23%)

12:45
11/15/18
11/15
12:45
11/15/18
12:45
Conference/Events
WillScot management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

12:45
11/15/18
11/15
12:45
11/15/18
12:45
General news
Breaking General news story  »

Atlanta Federal Reserve…

CME

CME Group

$188.85

0.77 (0.41%)

12:45
11/15/18
11/15
12:45
11/15/18
12:45
Hot Stocks
CME Group energy futures, options volume reaches record 5.1M contracts »

CME Group announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

CSIQ

Canadian Solar

$14.67

0.94 (6.85%)

12:42
11/15/18
11/15
12:42
11/15/18
12:42
Upgrade
Canadian Solar rating change  »

Canadian Solar upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KR

Kroger

$30.07

-0.22 (-0.73%)

12:40
11/15/18
11/15
12:40
11/15/18
12:40
Options
$18.6M block of Kroger calls »

$18.6M block of Kroger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.